trans-1-(9-anthryl)-2-nitroethylene | 55446-60-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 蒽
• 英文名称: trans-1-(9-anthryl)-2-nitroethylene
• 英文别名: 9-(2-Nitrovinyl)anthracene；9-[(E)-2-nitroethenyl]anthracene
• CAS: 55446-60-1
• 化学式: C₁₆H₁₁NO₂
• 分子量: 249.269
• InChiKey: GYOMWYPUMGJROJ-MDZDMXLPSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5
• 重原子数：
  19
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  45.8
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  trans-1-(9-anthryl)-2-nitroethylene 在 sodium hydrogensulfite 作用下， 以 aq. phosphate buffer 、 乙醇 为溶剂， 生成
  参考文献：
  名称：

  A new fluorescent enhanced probe based on (E)-9-(2-nitrovinyl)-anthracene for the detection of bisulfite anions and its practical application

  摘要：

  A new fluorescent enhanced probe based on (E)-9-(2-nitrovinyl)-anthracene is developed, which shows high selectivity and sensitivity for the detection of bisulfite anions at Na2HPO4 citric acid buffer solutions (pH 5.0). When addition of HSO3-, the fluorescence intensity is significantly enhanced and the probe displays apparent fluorescence color changes from non-fluorescence to blue under a UV lamp illumination, the solution color also changes from yellow to colorless. The detection limit is determined to be as low as 6.30 mu M. This offers another specific calorimetric and fluorescent probe for bisulfite anions detection, furthermore it is applied in detecting the level of bisulfite in sugar samples. (C) 2015 Elsevier B.V. All rights reserved.

  DOI：

  10.1016/j.saa.2015.03.074
• 作为产物：
  描述：

  顺式-1-(9-蒽基)-2-硝基乙烯 以 二氯甲烷 为溶剂， 生成 trans-1-(9-anthryl)-2-nitroethylene
  参考文献：
  名称：

  Photochemical isomerization and dimerization of 1-(9-anthryl)-2-nitroethylene

  摘要：

  DOI：

  10.1021/jo00366a035

文献信息

• Copper Catalyzed Synthesis of 3‐Nitro‐Quinolines from Nitro‐Olefins and Anthranils: Its Application in the Synthesis of Quindoline
  作者：Annapurna Awasthi、Pushpendra Yadav、Sourabh Yadav、Dharmendra Kumar Tiwari

  DOI：10.1002/adsc.202100861

  日期：2022.1.4

  Copper-catalyzed routes have been achieved for the synthesis of 3-nitroquinolines from readily available nitroolefins and anthranils. This reaction proceeds via the [4+2] cycloaddition between anthranils and nitro-styrenes under mild reaction conditions to obtain biologically important heterocycles. A wide range of diversely substituted nitro-olefins and anthranils are successfully employed in this

  铜催化路线已实现从容易获得的硝基烯烃和邻氨基苯甲酸合成 3-硝基喹啉。此反应的进行经由anthranils和硝基-苯乙烯之间温和的反应条件下进行[4 + 2]环加成以获得生物学上重要的杂环。在该反应中成功地使用了多种不同取代的硝基烯烃和邻氨基苯甲酸，以 81-93% 的产率获得了一系列 3-硝基喹啉。本手稿还说明了本方法的综合效用。
• Synthesis of 3-Substituted 2-Aminonaphtho[2,3-<i>b</i>]furan-4,9-diones from 2-Hydroxy-1,4-Naphthoquinone and Nitroalkenes
  作者：Manoj R. Zanwar、Veerababurao Kavala、Sachin D. Gawande、Chun-Wei Kuo、Ting-Shen Kuo、Mei-Ling Chen、Chiu-Hui He、Ching-Fa Yao

  DOI：10.1002/ejoc.201300996

  日期：2013.12

  The efficient base-catalyzed synthesis of 3-substituted 2-aminonaphtho[2,3-b]furan-4,9-dione derivatives from readily available precursors such as 2-hydroxy-1,4-naphthoquinone and nitroalkenes under aqueous conditions is described. Interesting features of this methodology are the conversion of a nitro functionality into an amino functionality in the absence of a reducing agent and the development of

  描述了在水性条件下从容易获得的前体（例如 2-羟基-1,4-萘醌和硝基烯烃）有效碱催化合成 3-取代 2-氨基萘[2,3-b]呋喃-4,9-二酮衍生物. 这种方法的有趣特征是在没有还原剂的情况下将硝基官能团转化为氨基官能团，并开发了一种三组分反应，用于从醛、2-羟基-1,4-萘醌和硝基甲烷。
• Synthesis, Antiproliferative and Pro-Apoptotic Effects of Nitrostyrenes and Related Compounds in Burkitt's Lymphoma
  作者：Andrew J. Byrne、Sandra A. Bright、Darren Fayne、James P. McKeown、Thomas McCabe、Brendan Twamley、Clive Williams、Mary J. Meegan

  DOI：10.2174/1573406413666171002123907

  日期：2018.2.6

  identified as a lead target structure for the development of particularly effective compounds targeting Burkitt's lymphoma (BL). OBJECTIVES The aims of the curent study were to synthesise a panel of nitrostyrene compounds and to evaluate their activity in Burkitt's lymphoma (BL). METHODS A panel of structurally varied compounds were designed and synthesised using Henry Knoevenagel condensation reactions.

  背景技术淋巴细胞癌（淋巴瘤）约占全世界恶性疾病的12％。硝基苯乙烯支架被认为是开发针对Burkitt淋巴瘤（BL）的特别有效的化合物的主要靶标结构。目的目前的研究目的是合成一组硝基苯乙烯化合物并评估其在伯基特氏淋巴瘤（BL）中的活性。方法使用Henry Knoevenagel缩合反应设计和合成一组结构变化的化合物。单晶X射线分析证实了这些新颖结构的六个实例的E构型。还研究了许多与硝基苯乙烯有关的化合物，包括1，3-双（芳基）-2-硝基丙烯与含有硝基乙烯基药效团的杂环支架，例如3-硝基-2-苯基-2H-色烯。使用BL细胞系EBV-MUTU-1和EBV + DG-75（耐化学性）评估化合物的抗增殖活性，以建立初步的结构活性关系。结果成功建立了具有优化的硝基苯乙烯骨架和3-硝基-2-苯基-2Hchromne结构的铅化合物，在MUTU-1细胞中的典型IC50值分别为0.45 µM和0.47 µM，
• What Controls Regiochemistry in 1,3-Dipolar Cycloadditions of Münchnones with Nitrostyrenes?
  作者：Justin M. Lopchuk、Russell P. Hughes、Gordon W. Gribble

  DOI：10.1021/ol402385v

  日期：2013.10.18

  The distinct experimentally observed regiochemistries of the reactions between mesoionic münchnones and β-nitrostyrenes or phenylacetylene are shown by DFT/BDA/ETS-NOCV analyses of the transition states to be dominated by steric and reactant reorganization factors, rather than the orbital overlap considerations predicted by Frontier Molecular Orbital (FMO) Theory.

  DFT / BDA / ETS-NOCV分析表明，过渡态受空间和反应物重组因素支配，而不是通过预测的轨道重叠因素来控制，从实验上观察到的中离子慕尼黑金属与β-硝基苯乙烯或苯乙炔之间反应的区域化学前沿分子轨道（FMO）理论。
• Design, Synthesis and Biochemical Evaluation of Novel Ethanoanthracenes and Related Compounds to Target Burkitt’s Lymphoma
  作者：Andrew J. Byrne、Sandra A. Bright、James P. McKeown、John E. O’Brien、Brendan Twamley、Darren Fayne、D. Clive Williams、Mary J. Meegan

  DOI：10.3390/ph13010016

  日期：——

  Burkitt’s lymphoma (BL) is a rare form of non-Hodgkin’s lymphoma in which the cancer starts in the immune B-cells. We report the synthesis and preliminary studies on the antiproliferative activity of a library of 9,10-dihydro-9,10-ethanoanthracene based compounds structurally related to the antidepressant drug maprotiline against BL cell lines MUTU-1 and DG-75. Structural modifications were achieved by Diels-Alder

  淋巴瘤（淋巴系统癌）占全世界恶性疾病的12％。伯基特氏淋巴瘤（BL）是非霍奇金淋巴瘤的一种罕见形式，其癌症始于免疫B细胞。我们报告了9,10-dihydro-9,10-ethanananthracene基化合物与抗抑郁药Maprotiline对BL细胞系MUTU-1和DG-75结构相关的化合物的合成和抗增殖活性的初步研究。通过使9-（2-硝基乙烯基）蒽核心与许多亲二烯体包括马来酸酐，马来酰亚胺，丙烯腈和苯炔的狄尔斯-阿尔德反应进行结构修饰。在BL细胞系EBV- MUTU-1和EBV + DG-75（耐化学性）中评估了这些化合物的抗增殖活性。最有效的化合物13j，15、16a，16b，16c，图16d和19a显示的相对于BL细胞系EBV- MUTU-1的IC50值在0.17–0.38μM范围内，相对于耐化学性BL细胞系EBV + DG-75的IC50值在0.45–0.78μM范围内。化合物1

表征谱图